Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases”
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | IJU Case Reports |
| Online Access: | https://doi.org/10.1002/iju5.12805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846098532611653632 |
|---|---|
| author | Manabu Kato |
| author_facet | Manabu Kato |
| author_sort | Manabu Kato |
| collection | DOAJ |
| format | Article |
| id | doaj-art-0c52cc90e5a54c26b89e7e328bb037b7 |
| institution | Kabale University |
| issn | 2577-171X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | IJU Case Reports |
| spelling | doaj-art-0c52cc90e5a54c26b89e7e328bb037b72025-01-01T23:35:59ZengWileyIJU Case Reports2577-171X2025-01-018191010.1002/iju5.12805Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases”Manabu Kato0Department of Urology Aichi Cancer Center Hospital Nagoya Aichi Japanhttps://doi.org/10.1002/iju5.12805 |
| spellingShingle | Manabu Kato Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases” IJU Case Reports |
| title | Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases” |
| title_full | Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases” |
| title_fullStr | Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases” |
| title_full_unstemmed | Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases” |
| title_short | Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases” |
| title_sort | editorial comment on efficacy of pembrolizumab plus lenvatinib as first line treatment for metastatic renal cell carcinoma with multiple brain metastases |
| url | https://doi.org/10.1002/iju5.12805 |
| work_keys_str_mv | AT manabukato editorialcommentonefficacyofpembrolizumabpluslenvatinibasfirstlinetreatmentformetastaticrenalcellcarcinomawithmultiplebrainmetastases |